P/E společnosti Hutchison China MediTech
Jaká je hodnota metriky P/E společnosti Hutchison China MediTech?
Hodnota metriky P/E společnosti Hutchison China MediTech Ltd. je N/A
Jaká je definice metriky P/E?
P/E ratio je koeficient daný poměrem ceny akcie a příjmu společnosti na akcii za posledních 12 měsíců.
The price to earnings ratio is the most widely used method for determining whether shares are accurately valued in relation to one another. But the P/E ratio does not in itself indicate whether the share is a bargain. The P/E ratio depends on the market’s perception of the risk and future growth in earnings. A company with a low P/E ratio indicates that the market perceives it as a higher risk or a lower growth or both as compared to a company with a higher price to earnings ratio. The P/E ratio of a listed company’s stock is the result of the collective perception of the market as to how risky the company is and what its earnings growth prospects are in relation to that of other companies. Investors use the P/E ratio to compare their own perception of the risk and growth of a company against the market’s collective perception of the risk and growth as reflected in the current P/E ratio.
P/E společností v sektoru Health Care sektor na LSE ve srovnání se společností Hutchison China MediTech
Čemu se věnuje společnost Hutchison China MediTech?
HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases worldwide. It operates in two segments, Oncology/Immunology and Other Ventures. It manufactures, distributes, markets, and sells prescription and over-the-counter pharmaceutical, and consumer health products. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and clear cell renal cell carcinoma, colorectal cancer (CRC), and gastric cancer (GC); and Fruquintinib, an inhibitor for CRC, breast cancer, GC, endometrial cancer (EMC), NSCLC, hepatocellular carcinoma, and gastrointestinal and solid tumors. It also develops Surufatinib, an inhibitor for neuroendocrine tumors (NET), pancreatic NET, non-pancreatic NET, biliary tract cancer, sarcoma, neuroendocrine neoplasm, esophageal cancer, small cell lung cancer, GC, thyroid cancer, EMC, NSCLC, and solid tumors; HMPL-523, an inhibitor for indolent non-Hodgkin's lymphoma (NHL), B-cell malignancies, and immune thrombocytopenic purpura; and HMPL-689 for indolent non-Hodgkin's, follicular, marginal zone, mantle cell, diffuse large B cell, chronic lymphocytic leukemia/small lymphocytic, and Hodgkin's lymphoma. The company develops HMPL-453, an inhibitor for intrahepatic cholangiocarcinoma; HMPL-306, an inhibitor for hematological malignancies, gliomas, and solid tumors; HMPL-295 for solid tumors; and HMPL-813 and HMPL-309 EGFR inhibitors. It has collaboration agreements with AstraZeneca AB (publ), Lilly (Shanghai) Management Company Limited, BeiGene, Inmagene Biopharmaceuticals Co. Ltd., Innovent Biologics (Suzhou) Co., Inc., Genor Biopharma Co. Ltd., Shanghai Junshi Biosciences Co. Ltd., and Epizyme, Inc. The company was formerly known as Hutchison China MediTech Limited and changed its name to HUTCHMED (China) Limited in May 2021. HUTCHMED (China) Limited was incorporated in 2000 and is headquartered in Central, Hong Kong.
Firmy s metrikou p/e podobnou společnosti Hutchison China MediTech
- Hodnota metriky P/E společnosti Open Orphan plc je N/A
- Hodnota metriky P/E společnosti Fidelity Asian Values Plc je N/A
- Hodnota metriky P/E společnosti Nel Asa je N/A
- Hodnota metriky P/E společnosti Fission Uranium je N/A
- Hodnota metriky P/E společnosti ECO Animal Health plc je N/A
- Hodnota metriky P/E společnosti Inox Leisure je N/A
- Hodnota metriky P/E společnosti Hutchison China MediTech je N/A
- Hodnota metriky P/E společnosti Huayi Tencent Entertainment je N/A
- Hodnota metriky P/E společnosti Kesar Petroproducts je N/A
- Hodnota metriky P/E společnosti Shanghai Bright Power Semiconductor Co je N/A
- Hodnota metriky P/E společnosti American Airlines Inc je N/A
- Hodnota metriky P/E společnosti American Pacific Borates je N/A
- Hodnota metriky P/E společnosti Hexa Tradex je N/A